Home›Infectious Disease› Neonatal neutrophil function varies by assay; chemotaxis and NETs often constrained
Neonatal neutrophil function varies by assay; chemotaxis and NETs often constrainedUnderstanding How Immune Cells Protect Newborns from Serious Infections
Frontiers in MedicinePublished August 15, 2026Study authors: Qiu-xiang Zhou, Zhi-qiang BaoDOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider neutrophil function as context-dependent; chemotaxis and NETs often constrained, but other functions may be preserved.
This is a mini review (systematic in approach) that synthesizes findings from human neonatal studies on neutrophil function. The scope covers sepsis, hypoxic-ischemic encephalopathy, bronchopulmonary dysplasia, and necrotizing enterocolitis, focusing on neonatal neutrophils. The review examines several functional outcomes: chemotaxis, extracellular-trap formation, phagocytosis, oxidative burst, granule content, and degranulation.
Key findings indicate that chemotaxis and extracellular-trap formation are often developmentally constrained in human neonatal studies. In contrast, phagocytosis, oxidative burst, granule content, and degranulation can be relatively preserved under specific assay conditions. The authors do not report pooled effect sizes; conclusions are qualitative.
The authors note important limitations: there is no clinically validated neonatal neutrophil-state classifier, and proposed interventions (targeting extracellular traps, myeloperoxidase, trained immunity, lipid mediators, or efferocytosis) remain experimental. No safety data or adverse events were reported.
Practice relevance: Evidence favors a context-dependent approach that preserves antimicrobial defense while testing ways to limit tissue injury. However, given the lack of clinical validation and experimental nature of interventions, clinicians should interpret these findings cautiously and await further research.
How this fits prior evidence
This mini review extends prior coverage by focusing on neonatal neutrophil function as a mechanistic underpinning for sepsis and related conditions. It complements earlier findings that tachypnoea ≥60 bpm increases mortality odds in infant sepsis and that IgM-enriched immunoglobulin shows inconclusive results, by highlighting potential cellular targets. The review also contrasts with the biomarker ANXA3's superior predictive accuracy, suggesting that functional assays may offer additional insights. However, the lack of a validated neutrophil-state classifier limits clinical translation, aligning with the experimental status of interventions.
When newborns face severe illnesses like sepsis or lung problems, their immune systems must work quickly. A specific type of white blood cell called a neutrophil is the first line of defense against germs. These cells are vital for fighting off infections in the very early stages of life.
Scientists have found that these cells behave differently than those in adults. While some parts of their defense system are still developing, other functions like eating germs and releasing chemicals to kill bacteria remain strong. This means they can still protect babies even while their systems are maturing.
Doctors are currently looking for ways to balance this immune response. The goal is to keep the cells active enough to fight infections but calm enough to prevent damage to the baby's healthy tissues. Because these treatments are still being tested, researchers are focusing on how different conditions affect cell behavior.
What this means for you:
Immune cells in newborns can effectively fight germs even while their systems are still developing.
Common questions
What specific immune functions were found to be limited in newborns?
The review found that chemotaxis and extracellular-trap formation are often developmentally constrained in human neonatal studies. These processes are part of how the body's white blood cells respond to infection. Because these functions are often limited, they are a primary focus for researchers looking at how infants fight severe illnesses like sepsis.
Which immune functions remained active in babies with serious conditions?
Some functions, including phagocytosis, oxidative burst, granule content, and degranulation, can be relatively preserved under specific assay conditions. This means that even when some parts of the immune system are limited, other components may still be working to provide a defense against infection in newborns with conditions like bronchopulmonary dysplasia.
Are there currently new treatments for these immune issues?
The research notes that several proposed interventions, such as those involving extracellular traps or lipid mediators, remain experimental. There is currently no clinically validated classifier to determine the state of these cells in patients. You should speak with a medical professional regarding specific treatments for neonatal conditions.
Neonatal neutrophils are often described as immature effector cells with limited marrow reserves and reduced antimicrobial capacity. This account is clinically useful but incomplete: individual functions mature at different rates, neutrophil populations are heterogeneous, and observed phenotypes vary with gestational age, maternal health, tissue context, and time after injury. This Mini Review first places neonatal findings against canonical mature-neutrophil functions, then examines context-dependent programs in neonatal sepsis, hypoxic-ischemic encephalopathy, bronchopulmonary dysplasia, and necrotizing enterocolitis. We use state as an operational, cross-sectional description supported by phenotypic, functional, or molecular evidence, without assuming a stable lineage or a proven conversion from inflammatory to reparative cells. Temporal change may instead reflect emergency granulopoiesis, selective recruitment, survival, clearance, or population replacement. Human neonatal studies show that chemotaxis and extracellular-trap formation are often developmentally constrained, whereas phagocytosis, oxidative burst, granule content, and degranulation can be relatively preserved under specific assay conditions. Disease models further reveal competing roles for neutrophils in pathogen control, thromboinflammation, angiogenic support, and resolution. Conflicting findings on extracellular traps in necrotizing enterocolitis illustrate why model, microbial burden, intervention timing, and whether an experiment prevents trap formation or removes established traps must be distinguished. No clinically validated neonatal neutrophil-state classifier exists. Routine laboratory values provide clinical context and trajectories, whereas proposed interventions targeting extracellular traps, myeloperoxidase, trained immunity, lipid mediators, or efferocytosis remain experimental. Taken together, the evidence favors a context-dependent approach that preserves antimicrobial defense while testing ways to limit tissue injury.
